Robert Lustig, MD: cracking the TOFI Code 'Thin on the Outside and Fat Inside' #nafld #sugar #tofi

preview_player
Показать описание
Click on the play link below the short video to see the full video.

Cracking the TOFI Code: Dr. Robert Lustig Explores NAFLD, Sugar, and Hidden Health Risks #TOFI #NAFLD #sugar
how would you know if you are a TOFI ?

Watch the full video where Professor Robert Lustig challenges the conventional wisdom on whether obesity is the primary driver of Non-Alcoholic Fatty Liver Disease (NAFLD) can be an eye-opening experience that provides a deeper understanding of this complex and often misunderstood health issue.

NAFLD is a condition characterized by the accumulation of fat in the liver of individuals who consume little to no alcohol. Traditionally, it has been widely believed that obesity is the primary cause of NAFLD, and this belief has led to many public health recommendations and interventions aimed at weight management as a means of preventing and treating the disease.

However, Professor Robert Lustig's perspective challenges this conventional wisdom. In the video, he delves into several key arguments and areas of research that challenge the direct link between obesity and NAFLD:

**Metabolic Health:** Professor Lustig emphasize that not all obese individuals develop NAFLD, while some lean individuals do. This suggests that factors other than body weight may play a crucial role in the development of the disease.

**Dietary Factors:** He discuss the importance of dietary choices and their impact on NAFLD. High sugar and high fructose corn syrup consumption, for instance, have been implicated in liver fat accumulation, even in individuals who are not obese.

**Insulin Resistance:** Professor Lustig delve into the concept of insulin resistance and its role in NAFLD. Insulin resistance can occur independently of obesity and is linked to metabolic disturbances that contribute to liver fat buildup.

**Genetics:** Professor Lustig also discuss the role Genetic play. Some individual may be predispose to NAFLD, and these factors are not solely tied to body weight.

**Inflammation:** Professor Lustig may discuss the role of inflammation in NAFLD and how factors beyond obesity, such as a pro-inflammatory diet or certain medical conditions, can contribute to liver inflammation and damage.

**Physical Activity:** Physical activity and muscle mass can influence metabolic health and may protect against NAFLD, even in individuals with excess body weight.

By watching the full video, you would have the opportunity to gain a comprehensive understanding of Professor Lustig's arguments, the scientific evidence he presents, and his alternative perspective on the relationship between obesity and NAFLD. It's important to approach this information with an open mind and consider the broader implications it may have for public health recommendations and the understanding of metabolic diseases. Ultimately, the video may challenge preconceived notions and inspire further research and discussion on the topic.

About Emery Pharma:
Emery Pharma is deeply committed to advancing public health and exclusively focuses on projects that enhance the well-being of both individuals and the environment. As a comprehensive contract research laboratory, Emery Pharma provides extensive support across the entire spectrum of pharmaceutical development, covering small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.

Emery Pharma's array of premium services includes analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and comprehensive R&D with cGMP/GLP support. The Emery Pharma team excels in customizing innovative solutions tailored to the unique requirements of each client. They seamlessly oversee the entire process, from initial drug discovery to thorough data analysis and insights generation. Their expertise allows them to tackle scientific challenges proactively, ensuring clients avoid unnecessary setbacks.

Emery Pharma's accomplished chemists and biologists harness state-of-the-art technology, encompassing cutting-edge tools such as high-resolution mass spectrometry (Orbitrap), triple quad LC-MS/MS, GC-MS, preparative HPLC, and 400 MHz multinuclear NMR.

Рекомендации по теме
Комментарии
Автор

Keep educating the people and ignore the uneducated commentary. I’ve enjoyed your presentations for many years. Great job, Dr. Lustig.

jlsquire
Автор

Jordan Peterson, is that you? Complete with the sudden angry voice as if to be... convincing

seheyt
Автор

That guy just lost all credibility with this short video. Fat cells are not inert. They produce hormones they can maintain health or cause disease, Regardless of whether it’s visceral, or subcutaneous fat.

baconjanet